DexCom Inc (DXCM)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	597,700	506,200	448,200	397,100	391,200	266,400	237,200	261,200	265,800	369,200	345,000	311,800	299,500	297,000	258,900	190,300	142,300	-123,800	-165,900	-170,000
Revenue (ttm)	US$ in thousands	3,603,200	3,380,700	3,175,600	3,001,700	2,889,200	2,740,300	2,599,600	2,478,000	2,333,800	2,206,500	2,058,200	1,914,400	1,823,900	1,754,600	1,659,800	1,555,100	1,426,800	1,302,000	1,187,500	1,108,600
Operating profit margin		16.59%	14.97%	14.11%	13.23%	13.54%	9.72%	9.12%	10.54%	11.39%	16.73%	16.76%	16.29%	16.42%	16.93%	15.60%	12.24%	9.97%	-9.51%	-13.97%	-15.33%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $597,700K ÷ $3,603,200K
= 16.59%

Dexcom Inc's operating profit margin has shown a positive trend over the past eight quarters, indicating improving efficiency in generating profits from its core operations. The company's operating profit margin increased steadily from Q1 2022 to Q4 2023, with a notable uptick in the last two quarters. This performance suggests that Dexcom has been successful in controlling its operating expenses relative to its revenue, leading to higher profitability. The latest operating profit margin of 16.55% in Q4 2023 reflects a strong financial position and efficient management of operational costs. Overall, the increasing trend in operating profit margin is a positive indicator of Dexcom's operational efficiency and profitability.